Skip to main content
. 2020 Dec 4;9(12):3941. doi: 10.3390/jcm9123941

Figure 2.

Figure 2

Kinetics of SIBDQ (A) and VAS (B) scores from T0 to T2 in UC patients treated with BLM add-on therapy and in the control group. Comparison between groups at different time-points was performed by Students’ t-test. Abbreviations: microencapsulated sodium butyrate (BLM), Short Inflammatory Bowel Disease Questionnaire (SIBDQ), visual analogue scale (VAS).